Home Healthcare Pharmaceuticals Dementia Drugs Market

Dementia Drugs Market Size, Share & Trends Analysis Report By Indications (Lewy Body Dementia, Parkinsons Disease Dementia, Alzheimers Disease, Vascular Dementia, Other Indications), By Drug Class (MAO-B Inhibitors, Glutamate Inhibitors, Cholinesterase Inhibitors) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Dementia Drugs Market Size Analysis
    1. Introduction
    2. Dementia Drugs Market Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
      1. Lewy Body Dementia
      2. Parkinsons Disease Dementia
      3. Alzheimers Disease
      4. Vascular Dementia
      5. Other Indications
    3. Dementia Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. MAO-B Inhibitors
      2. Glutamate Inhibitors
      3. Cholinesterase Inhibitors
  7. North America Dementia Drugs Market Size Analysis
    1. Introduction
    2. Dementia Drugs Market Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
      1. Lewy Body Dementia
      2. Parkinsons Disease Dementia
      3. Alzheimers Disease
      4. Vascular Dementia
      5. Other Indications
    3. Dementia Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. MAO-B Inhibitors
      2. Glutamate Inhibitors
      3. Cholinesterase Inhibitors
    4. U.S.
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    5. Canada
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
  8. Europe Dementia Drugs Market Size Analysis
    1. Introduction
    2. Dementia Drugs Market Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
      1. Lewy Body Dementia
      2. Parkinsons Disease Dementia
      3. Alzheimers Disease
      4. Vascular Dementia
      5. Other Indications
    3. Dementia Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. MAO-B Inhibitors
      2. Glutamate Inhibitors
      3. Cholinesterase Inhibitors
    4. U.K.
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    5. Germany
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    6. France
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    7. Spain
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    8. Italy
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    9. Russia
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    10. Nordic
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    11. Benelux
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    12. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
  9. APAC Dementia Drugs Market Size Analysis
    1. Introduction
    2. Dementia Drugs Market Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
      1. Lewy Body Dementia
      2. Parkinsons Disease Dementia
      3. Alzheimers Disease
      4. Vascular Dementia
      5. Other Indications
    3. Dementia Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. MAO-B Inhibitors
      2. Glutamate Inhibitors
      3. Cholinesterase Inhibitors
    4. China
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    5. Korea
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    6. Japan
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    7. India
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    8. Australia
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    9. Taiwan
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    10. South East Asia
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    11. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
  10. Middle East and Africa Dementia Drugs Market Size Analysis
    1. Introduction
    2. Dementia Drugs Market Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
      1. Lewy Body Dementia
      2. Parkinsons Disease Dementia
      3. Alzheimers Disease
      4. Vascular Dementia
      5. Other Indications
    3. Dementia Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. MAO-B Inhibitors
      2. Glutamate Inhibitors
      3. Cholinesterase Inhibitors
    4. UAE
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    5. Turkey
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    6. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    7. South Africa
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    8. Egypt
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    9. Nigeria
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    10. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
  11. LATAM Dementia Drugs Market Size Analysis
    1. Introduction
    2. Dementia Drugs Market Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
      1. Lewy Body Dementia
      2. Parkinsons Disease Dementia
      3. Alzheimers Disease
      4. Vascular Dementia
      5. Other Indications
    3. Dementia Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. MAO-B Inhibitors
      2. Glutamate Inhibitors
      3. Cholinesterase Inhibitors
    4. Brazil
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    5. Mexico
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    6. Argentina
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    7. Chile
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    8. Colombia
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    9. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
  12. Competitive Landscape
    1. Dementia Drugs Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Apotex Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. AstraZeneca
    3. Aurobindo Pharma
    4. Eisai Co. Ltd
    5. Eli Lilly and Company
    6. Johnson & Johnson
    7. Pfizer Inc.
    8. Teva Pharmaceuticals
    9. Zydus Pharmaceuticals
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer

List of Tables

Table 1: Global Dementia Drugs Market Size and Forecast By Regions - 2022-2034 (USD Billion)

Table 2: Global Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 3: Global Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 4: North America Dementia Drugs Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 5: North America Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 6: North America Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 7: U.S. Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 8: U.S. Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 9: Canada Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 10: Canada Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 11: Europe Dementia Drugs Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 12: Europe Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 13: Europe Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 14: U.K. Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 15: U.K. Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 16: Germany Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 17: Germany Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 18: France Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 19: France Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 20: Spain Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 21: Spain Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 22: Italy Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 23: Italy Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 24: Russia Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 25: Russia Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 26: Nordic Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 27: Nordic Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 28: Benelux Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 29: Benelux Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 30: Rest of Europe Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 31: Rest of Europe Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 32: APAC Dementia Drugs Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 33: APAC Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 34: APAC Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 35: China Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 36: China Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 37: Korea Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 38: Korea Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 39: Japan Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 40: Japan Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 41: India Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 42: India Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 43: Australia Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 44: Australia Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 45: Taiwan Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 46: Taiwan Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 47: South East Asia Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 48: South East Asia Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 49: Rest of Asia-Pacific Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 50: Rest of Asia-Pacific Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 51: Middle East and Africa Dementia Drugs Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 52: Middle East and Africa Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 53: Middle East and Africa Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 54: UAE Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 55: UAE Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 56: Turkey Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 57: Turkey Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 58: Saudi Arabia Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 59: Saudi Arabia Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 60: South Africa Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 61: South Africa Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 62: Egypt Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 63: Egypt Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 64: Nigeria Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 65: Nigeria Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 66: Rest of MEA Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 67: Rest of MEA Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 68: LATAM Dementia Drugs Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 69: LATAM Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 70: LATAM Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 71: Brazil Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 72: Brazil Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 73: Mexico Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 74: Mexico Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 75: Argentina Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 76: Argentina Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 77: Chile Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 78: Chile Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 79: Colombia Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 80: Colombia Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 81: Rest of LATAM Dementia Drugs Market Size and Forecast By Indications - 2022-2034 (USD Billion)

Table 82: Rest of LATAM Dementia Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.